冰片
酶谱
口腔粘膜下纤维性变
化学
成纤维细胞
纤维化
基质金属蛋白酶
药理学
细胞毒性
体外
生物化学
医学
病理
中医药
替代医学
作者
Jianping Dai,Jun Chen,Yu‐Fei Bei,Bangxing Han,Sheng Wang
标识
DOI:10.1111/j.1600-0714.2008.00738.x
摘要
Background: Borneol, a widely used food and cosmetics additive, has analgesic, anti‐inflammatory, antibacterial and penetration enhancing effects. We try to use it as a penetration enhancer for a formula which we have used to treat oral submucous fibrosis (OSF). To assess its safety, we investigate its effects on primary mice oral fibroblasts. Methods: Primary mice oral fibroblasts were cultured, the effects of borneol on fibroblasts proliferation, cytotoxicity, collagen production, matrix metalloproteinases‐2,9 (MMP‐2,9) activities and tissue inhibitors of metalloproteinase 1 (TIMP‐1) production were tested by methyl thiazolyl tetrazolium assay, lactic dehydrogenase activity assay, chloramine T method, gelatin zymography and enzyme‐linked immunosorbent assay, respectively. Results: Borneol, from 18.75 to 300 μg/ml, could significantly ( P < 0.05) decrease the growth of fibroblasts and very significantly ( P < 0.01) inhibit collagen production in a concentration dependant manner. From 18.75 to 150 μg/ml, borneol had no cytotoxicity on mice oral fibroblasts. Moreover borneol could significantly ( P < 0.05) decrease MMP‐2 activity, and very significantly ( P < 0.01) inhibit TIMP‐1 production. Conclusions: This study indicates that borneol has anti‐fibrosis activity and the mechanism may partly be relevant to its inhibiting effects on fibroblasts mitosis, collagen and TIMP‐1 production. It can be safely used as a penetration enhancer for our formula to treat OSF.
科研通智能强力驱动
Strongly Powered by AbleSci AI